The store will not work correctly when cookies are disabled.
N-[4-(Diethylamino)phenyl]-5-phenyloxazole-4-carboxamide
ID: ALA4537081
PubChem CID: 60298320
Max Phase: Preclinical
Molecular Formula: C20H21N3O2
Molecular Weight: 335.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(CC)c1ccc(NC(=O)c2ncoc2-c2ccccc2)cc1
Standard InChI: InChI=1S/C20H21N3O2/c1-3-23(4-2)17-12-10-16(11-13-17)22-20(24)18-19(25-14-21-18)15-8-6-5-7-9-15/h5-14H,3-4H2,1-2H3,(H,22,24)
Standard InChI Key: JTYVDGGAASKBJQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
16.0935 -3.4132 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0905 -4.2345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8704 -4.4917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3549 -3.8305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8752 -3.1659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1274 -2.3864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9327 -2.2202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1878 -1.4405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6427 -0.8264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8351 -0.9972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5796 -1.7767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1762 -3.8322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5875 -4.5408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4088 -4.5425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8135 -5.2543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6341 -5.2564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0491 -4.5449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6335 -3.8340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8143 -3.8354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8705 -4.5456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2785 -5.2577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0998 -5.2584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2796 -3.8382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1009 -3.8388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5905 -3.1213 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
4 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
20 21 1 0
21 22 1 0
20 23 1 0
23 24 1 0
12 25 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 335.41 | Molecular Weight (Monoisotopic): 335.1634 | AlogP: 4.44 | #Rotatable Bonds: 6 |
Polar Surface Area: 58.37 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.75 | CX Basic pKa: 5.40 | CX LogP: 3.78 | CX LogD: 3.78 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.72 | Np Likeness Score: -1.46 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |